Lynx1 Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001910456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2025 · 22 positions · Total reported value $494.00M · Top-10 concentration 97.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 30.3% · 6 new · 2 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.3% · vs SPY -17.4% · Prev Value $865.53M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.1% · vs SPY -7.2% · Latest Value $646.09M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Lynx1 Capital Management LP disclosed 22 equity positions with a combined reported value of $494.00M. The filing implies a focused portfolio: its ten largest positions account for 97.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were STOK ($171.54M), GHRS ($132.16M), CGEM ($92.77M). By sector, the heaviest allocations are Health Care 100.0%, Other 0.0%. Versus the prior quarter, allocation shifted toward Health Care (+29.4pp) and away from Other (-29.4pp).

Versus the prior quarter, Lynx1 Capital Management LP opened 6 new positions, trimmed 2 and fully exited 2, a turnover rate of 30.3% of positions. The portfolio's overlap with the prior quarter was 33% of names.

The largest new positions opened in Q4 2025 were XNCR ($10.80M), IMTX ($9.68M), KRRO ($5.43M).

Of the 2 positions fully exited versus the prior quarter, the largest were MRUS ($144.44M), PTGX ($46.50M), ADCT ($5.30M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • XNCR XENCOR INC · $10.80M
  • IMTX Immatics NV · $9.68M
  • KRRO KORRO BIO INC · $5.43M
  • NEUP NEUPHORIA THERAPEUTICS INC · $3.40M
  • AGIO AGIOS PHARMACEUTICALS INC · $2.17M
  • CGON CG ONCOLOGY INC · $1.31M
  • ARWR ARROWHEAD PHARMACEUTICALS IN · $799.53K
  • TRDA ENTRADA THERAPEUTICS INC · $531.36K

Fully Exited (vs previous quarter)

  • MRUS MERUS N V · prev qtr: $144.44M
  • PTGX PROTAGONIST THERAPEUTICS INC · prev qtr: $46.50M
  • ADCT ADC THERAPEUTICS SA · prev qtr: $5.30M
  • IBIO IBIO INC · prev qtr: $874.07K
  • ALLO ALLOGENE THERAPEUTICS INC · prev qtr: $677.19K

Insider Transactions (Form 4)

Latest Lynx1 Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Buy Korro Bio, Inc. 25,124 $11.75 SEC filing
2026-10-23 Buy Korro Bio, Inc. 2,510 $12.11 SEC filing
2026-10-22 Buy Korro Bio, Inc. 40,000 $11.04 SEC filing
2026-10-22 Buy Korro Bio, Inc. 12,175 $9.68 SEC filing
2026-08-10 Buy Korro Bio, Inc. 1,462 $13.19 SEC filing
2026-08-06 Buy Korro Bio, Inc. 5,222 $11.40 SEC filing
2026-06-25 Buy Passage BIO, Inc. 50,055 $4.12 SEC filing

All insider transactions →

Fund Profile

Lynx1 Capital Management LP, based in Dorado, PR, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 31 positions worth $646.09M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: DORADO, PR, United States
  • SEC registration: 801-127585 (status: Approved), registered 2023-04-05
  • Regulatory AUM (Form ADV): $626.68M as of 2026-10-07
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds

Portfolio Structure

  • 31 positions · $646.09M reported value (Q3 2026)
  • Top 10 holdings = 97.9% of reported value
  • Largest position: GHRS (GH RESEARCH PLC) at 48.2%
  • Average position size: $20.84M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 6 new, 5 added, 2 reduced, 2 exited
  • 18 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 100.0%
Other 0.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.40M $171.54M 34.73%
34.73%
Hold
2 10.41M $132.16M 26.75%
26.75%
Add
3 8.96M $92.77M 18.78%
18.78%
Add
4 1.74M $28.71M 5.81%
5.81%
Add
5 7.10M $13.56M 2.74%
2.74%
Hold
6 705.56K $10.80M 2.19%
2.19%
New
7 921.95K $9.68M 1.96%
1.96%
New
8 8.02M $8.02M 1.62%
1.62%
Add
9 623.70K $7.36M 1.49%
1.49%
Hold
10 677.91K $5.43M 1.10%
Form 4 · 4 →
1.10%
New
11 993.91K $4.13M 0.84%
0.84%
Reduce
12 875.23K $3.40M 0.69%
0.69%
New
13 79.62K $2.17M 0.44%
0.44%
New
14 31.59K $1.31M 0.27%
0.27%
New
15 12.04K $799.53K 0.16%
0.16%
New
16 69.52K $652.06K 0.13%
0.13%
Add
17 51.69K $531.36K 0.11%
0.11%
New
18 655.93K $415.53K 0.08%
0.08%
New
19 13.48K $236.72K 0.05%
0.05%
New
20 25.00K $142.00K 0.03%
0.03%
New
21 68.49K $138.34K 0.03%
0.03%
New
22 410.50K $41.05K 0.01%
0.01%
New

FAQ

What did Lynx1 Capital Management LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Lynx1 Capital Management LP reported 22 equity positions worth $494.00M in aggregate; its largest disclosed positions were STOK ($171.54M), GHRS ($132.16M), CGEM ($92.77M).

How large is Lynx1 Capital Management LP's portfolio?

Lynx1 Capital Management LP reported $494.00M of long equity holdings across 22 positions as of 2025-Q4. Top-10 holdings account for 97.2% of reported value.

What is Lynx1 Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/lynx1-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →